Ex-vivo T-cell depletion with sequential CD34+selection and OKT3 depletion for graft versus host disease prophylaxis in related haplo-identical allogeneic stem cell transplant.

被引：0
|
作者：
McGuirk, J [1 ]
Seropian, S [1 ]
Berliner, N [1 ]
Sleight, B [1 ]
Beardsley, D [1 ]
Debelak, J [1 ]
Krause, DS [1 ]
Smith, B [1 ]
Cooper, D [1 ]
机构：
[1] Yale Univ, New Haven Hosp, New Haven, CT USA
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4986
引用
收藏
页码：393B / 393B
页数：1
相关论文
共 50 条
  • [21] Combining CD34+stem cell selection with prophylactic pathogen and leukemia directed T-cell immunotherapy to simultaneously reduce graft versus host disease, infection, and leukemia recurrence after allogeneic stem cell transplant
    Gottlieb, David J.
    Sutrave, Gaurav
    Jiang, Wei
    Avdic, Selmir
    Street, Janine A.
    Simms, Renee
    Clancy, Leighton E.
    Antonenas, Vicki
    Gloss, Brian S.
    Bateman, Caroline
    Bishop, David C.
    Micklethwaite, Kenneth P.
    Blyth, Emily
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (01) : 159 - 165
  • [22] Ex vivo T-cell depletion with CAMPATH 1G completely abrogates graft-versus-host disease (GVHD) in peripheral blood stem cell (PBSC) allografts
    Jacobs, P
    Wood, L
    Hale, G
    Waldman, H
    EXPERIMENTAL HEMATOLOGY, 1997, 25 (08) : 294 - 294
  • [23] Erratum: Case report: Haploidentical peripheral blood stem cell transplantation with a combination of CD34 selection and T cell depletion as graft-versus-host disease prophylaxis in a patient with severe combined immunodeficiency
    MP Martín-Hernández
    R Arrieta
    A Martínez
    P García
    V Jimenez-Yuste
    F Hernandez-Navarro
    Bone Marrow Transplantation, 1998, 21 : 743 - 743
  • [24] CD6+donor marrow T-cell depletion as the sole form of graft-versus-host disease prophylaxis in patients undergoing allogeneic bone marrow transplant from unrelated donors
    Soiffer, RJ
    Weller, E
    Alyea, EP
    Mauch, P
    Webb, IL
    Fisher, DC
    Freedman, AS
    Schlossman, RL
    Gribben, J
    Lee, S
    Anderson, KC
    Marcus, K
    Stone, RM
    Antin, JH
    Ritz, J
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (04) : 1152 - 1159
  • [25] IN VIVO T-CELL DEPLETION (TCD) DOES NOT IMPROVE RATES OF GRAFT-VERSUS-HOST DISEASE (GVHD) AND TRANSPLANTATION OUTCOMES IN PATIENTS UNDERGOING PERIPHERAL BLOOD ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANT (AHCT)
    Kanate, A. S.
    Osman, S.
    Cumpston, A.
    Hobbs, G.
    Leadmon, S.
    Bunner, P.
    Gibson, L.
    Tse, W.
    Abraham, J.
    Remick, S.
    Craig, M.
    Hamadani, M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S309 - S310
  • [26] GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS WITH ANTI-T-CELL MONOCLONAL-ANTIBODY OKT3, PREDNISONE AND METHOTREXATE IN ALLOGENEIC BONE-MARROW TRANSPLANTATION
    FILIPOVICH, AH
    KRAWCZAK, CL
    KERSEY, JH
    MCGLAVE, P
    RAMSAY, NKC
    BRITISH JOURNAL OF HAEMATOLOGY, 1985, 60 (01) : 143 - 152
  • [27] Haploidentical peripheral blood stem cell transplantation with a combination of CD34 selection and T cell depletion as graft-versus-host disease prophylaxis in a patient with severe combined immunodeficiency (vol 20, pg 797, 1997)
    Martín-Hernández, MP
    Arrieta, R
    Martínez, A
    García, P
    Jimenez-Yuste, V
    Hernandez-Navarro, F
    BONE MARROW TRANSPLANTATION, 1998, 21 (07) : 743 - 743
  • [28] In-vivo T-cell depletion with rabbit anti-thymocyte globulin prevents severe acute- and chronic-graft-versus host disease and allows safe allogeneic stem cell
    Slack, J.
    Leis, J.
    Reeder, C.
    Mikhael, J.
    Noel, P.
    Mesa, R.
    Tibes, R.
    Betcher, J.
    Adams, R.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S402 - S402
  • [29] Humanized anti-CD25 monoclonal antibody for prophylaxis of graft-vs-host disease (GVHD) in haploidentical bone marrow transplantation without ex vivo T-cell depletion
    Chen, HR
    Ji, SQ
    Wang, HX
    Yan, HM
    Zhu, L
    Liu, J
    Xue, M
    Xun, CQ
    EXPERIMENTAL HEMATOLOGY, 2003, 31 (11) : 1019 - 1025
  • [30] Late Toxicities in Long-Term Survivors of Adult Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) Using Ex-Vivo CD34+Selection-Based Graft-Versus-Host Disease (GVHD) Prophylaxis
    Scordo, M.
    Shah, G. L.
    Devlin, S.
    Maloy, M.
    Kosuri, S.
    Herrera, D. Adrianzen
    Nieves, J.
    Avecilla, S. T.
    Meagher, R. C.
    Gyurkocza, B.
    Castro-Malaspina, H.
    Tamari, R.
    Perales, M. -A.
    Giralt, S. A.
    Shaffer, B.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S419 - S420
12345